Medtronic (MDT)

Medtronic has undergone a business revamp and is now ready to grow again, including by leaning into acquisitions.

Medtronic (MDT) stock jumps after beating Q4 revenue expectations, driven by strong growth in cardiovascular and diabetes tech.

Medtronic (NYSE:MDT) reported what executives described as its strongest top-line performance in a decade, as growth in cardiac ablation, diabetes, medical-surgical products and select neuroscience platforms helped drive fiscal fourth-quarter and full-year results above expectations. Chairman and C

Medtronic stock jumped Wednesday after the medical products giant said it requested new clearances in robotic surgery.

Medtronic to report Q4 2026 results with expected revenue of $9.61B and EPS of $1.55. Dividend yield is 3.83%.

Medtronic (MDT) to report Q4 2026 results on 6/3, expected revenue of $9.61B & EPS of $1.55. Recent acquisition of SPR Therapeutics adds to neuromodulation business. Analyst ratings show mixed opinions.

High energy prices have investors worried about a recession; these businesses should survive the hit just fine.

The most recent research report on the "Hemodialysis Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forecasts, and p

The most recent research report on the "Nitinol Medical Devices Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forec

(BPT) - Key takeaways

The most recent research report on the "ENT Handheld Instruments Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic fore

One is a well-known pharmaceutical company; the other is the king of the medical device segment.

This medical device maker has deep industry connections and is pushing further into an attractive industry niche.

Many investors understandably have doubts about the company right now.

(BPT) - Healthcare technology entered 2026 smarter, faster, and more connected than ever. From creating digital twins of real people to artificial intelligence (AI) gaining momentum, here are trends experts at health-tech company Medtronic say could define this year.

These three stocks are deeply unloved, giving them material upside, and they have great businesses.

Medtronic is closing in on Dividend King status, and its surgical robot is gaining traction.

If you are trying to generate income in retirement, these three high-yield healthcare stocks could be the perfect fit for you.

Intuitive Surgical's success hints that this competitor could have more growth potential than investors think.